![Timothy Block](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Block
Fondateur chez
Hepatitis B Foundation
Fortune : - $ au 30/06/2026
Profil
Timothy M.
Block is the founder of Glycotest, Inc., founded in 2012, and MERLIN Biotech LLC, founded in 2022, where the title held is Chairman.
Dr. Block is also the founder of Hepatitis B Foundation,Baruch S.
Blumberg Institute,Hatch Biofund Management LLC..
Dr. Block currently holds the positions of President & Chief Executive Officer at Bucks County Biotechnology Center, Inc., Independent Director at Hepion Pharmaceuticals, Inc. since 2013, and Professor-Microbiology & Immunology at Drexel University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 7 ( 0 % ) | 0 $ | 30/06/2026 |
Postes actifs de Timothy Block
| Sociétés | Poste | Début |
|---|---|---|
Hepatitis B Foundation
 Hepatitis B Foundation The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, advocacy, and patient support. The non-profit company is based in Doylestown, PA. The foundation provides educational resources on hepatitis B prevention, diagnosis, treatment, and management, emphasizing vaccination, testing, and early intervention. It addresses special populations such as children and individuals coinfected with HIV, offers expert guidelines and support programs, combats stigma and discrimination, and advocates for patients’ rights. The foundation supports patients and healthcare providers with clinical trial information, physician directories, medication assistance, online support groups, and training programs. The company was founded by Joan M. Block, Timothy M. Block. Louis P. Kassa has been the CEO of the company since 2022. | Fondateur | - |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Pennsylvania Biotechnology Center of Bucks County
 Pennsylvania Biotechnology Center of Bucks County Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit research organization | Directeur Général | - |
Baruch S. Blumberg Institute
 Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | Fondateur | - |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management invests in companies located in the United States. The firm focuses on the biotechnology sectors. it participates in the early stage capital requirements. | Fondateur | - |
Anciens postes connus de Timothy Block
| Sociétés | Poste | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/06/2026 |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Hepatitis B Foundation
Hepatitis B Foundation The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, advocacy, and patient support. The non-profit company is based in Doylestown, PA. The foundation provides educational resources on hepatitis B prevention, diagnosis, treatment, and management, emphasizing vaccination, testing, and early intervention. It addresses special populations such as children and individuals coinfected with HIV, offers expert guidelines and support programs, combats stigma and discrimination, and advocates for patients’ rights. The foundation supports patients and healthcare providers with clinical trial information, physician directories, medication assistance, online support groups, and training programs. The company was founded by Joan M. Block, Timothy M. Block. Louis P. Kassa has been the CEO of the company since 2022. | |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pennsylvania Biotechnology Center of Bucks County
Pennsylvania Biotechnology Center of Bucks County Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit research organization | Commercial Services |
Baruch S. Blumberg Institute
Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis | Electronic Technology |
Hatch Biofund Management LLC
Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management invests in companies located in the United States. The firm focuses on the biotechnology sectors. it participates in the early stage capital requirements. | Finance |
